Showing results (181-190 of 980) with videos related to

Sort By:
Pageof 98
Cardiovascular Therapeutics|April 16, 2020
Extracorporeal Hemadsorption versus Glucocorticoids during Cardiopulmonary Bypass: A Prospective, Randomized, Controlled TrialGordana Taleska Stupica, Maja Sostaric, Marija Bozhinovska, et al.
Cardiovascular Therapeutics|April 24, 2015
Modulation of adhesion molecules by cholesterol-lowering therapy in mononuclear cells from hypercholesterolemic patientsAlvaro Cerda, Alice Cristina Rodrigues, Camila Alves, et al.
Cardiovascular Therapeutics|February 9, 2026
Potential Diagnostic and Therapeutic Uses of DPT in Acute Type A Aortic DissectionTing Wei, Xiaopeng Yang, Chao Shi
Cardiovascular Therapeutics|February 11, 2026
Impella Versus Selective Biatrial Canulation for Left Ventricular Unloading During Extracorporeal Membrane OxygenationMouhamed Djahoum Moussa, Jean Roux, Marie Jungling, et al.
Cardiovascular Therapeutics|January 15, 2026
Subclinical Hypothyroidism as a Risk for Coronary Artery Bypass GraftingRicardo Mendes Martins, Felipe José M Pittella, Beatriz C de Oliveira, et al.
Cardiovascular Therapeutics|January 16, 2026
Low-Dose Mavacamten Initiation in Obstructive Hypertrophic Cardiomyopathy: A Real-World Study in ChinaWenlong Yang, Hui Shi, Rebecca Suchi Chang, et al.
Cardiovascular Therapeutics|January 16, 2026
Aldehyde Dehydrogenase-2 Alleviates Septic Myocardial Injury by Inhibiting Caspase-11-Mediated Noncanonical PyroptosisHuan Liang, Yuying He, Yiren Wang, et al.
Cardiovascular Therapeutics|January 30, 2023
The Effect of Clinically Indicated Liraglutide on Pericoronary Adipose Tissue in Type 2 Diabetic PatientsIrmelin I A Biesenbach, Laurits J Heinsen, Katrine S Overgaard, et al.
Cardiovascular Therapeutics|January 30, 2023
Social App to Improve Warfarin Therapy in Post-MHVR Chinese Patients: A Randomized Controlled TrialLitao Zhang, Sha Li, Zishuo Li, et al.
Cardiovascular Therapeutics|November 9, 2012
Improved blood pressure control with nifedipine GITS/valsartan combination versus high-dose valsartan monotherapy in mild-to-moderate hypertensive patients from Asia: results from the ADVISE study, a randomized trialYuan-Nan Ke, Yu-Gang Dong, Shu-Ping Ma, et al.
Pageof 98